This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,779.44 firm fixed-price contract is for the supply of TRODELVY 180 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $6,007.00, is for the provision of 180 mg vials of the pharmaceutical drug TRODELVY. This is a firm fixed-price contract with a period of performance ending on July 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this award. The...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,017.50 order is for TRODELVY 180 MG VIALS, a specialty pharmaceutical product. The delivery order was not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and has been awarded numerous pharmaceutical and medical supply contracts with...
The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of TRODELVY 180 MG VIALS. The contract has a ceiling value of $15,017.50 and a period of performance through October 17, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range of essential...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a final completion date of February 13, 2025. This is a Firm Fixed Price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,035.00, is for the delivery of 180 mg TRODELVY vials, a specialty pharmaceutical product. The award has a firm fixed price and an ultimate completion date of August 12, 2024. This contract is not associated with any set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,007.00 firm fixed price order is for the supply of TRODELVY 180 MG VIALS to support military treatment programs and facilities. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TRODELVY 180 MG VIALS, with a completion date of March 12, 2024 and a potential value of $22,526.25. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is an experienced provider of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The specific contract award is for the supply of TRODELVY 180 MG VIALS, a specialty medication, at a ceiling value of $15,536.60. The contract has a firm fixed price and an ultimate completion date of January 2, 2025....